NO20082547L - Orale formuleringer omfattende tigecycline - Google Patents

Orale formuleringer omfattende tigecycline

Info

Publication number: NO20082547L
Authority: NO; Norway
Prior art keywords: tigecycline; oral formulations; mixture; disclosed; pharmaceutical compositions
Prior art date: 2005-12-22

Application number

NO20082547A

Other languages

English (en)

Norwegian (no)

Inventor

Syed Muzafar Shah

Kadum Abdul Nabi Ali

Christopher Richard Diorio

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-22

Filing date

2008-05-30

Publication date

2008-09-22

2008-05-30 Application filed by Wyeth Corp filed Critical Wyeth Corp

2008-09-22 Publication of NO20082547L publication Critical patent/NO20082547L/no

Links

FPZLLRFZJZRHSY-HJYUBDRYSA-N tigecycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=C(NC(=O)CNC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O FPZLLRFZJZRHSY-HJYUBDRYSA-N 0.000 title abstract 3
229960004089 tigecycline Drugs 0.000 title abstract 3
239000000203 mixture Substances 0.000 title abstract 2
238000009472 formulation Methods 0.000 title 1
239000002702 enteric coating Substances 0.000 abstract 1
238000009505 enteric coating Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20082547A 2005-12-22 2008-05-30 Orale formuleringer omfattende tigecycline NO20082547L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US75303505P	2005-12-22	2005-12-22
PCT/US2006/048621 WO2007075794A2 (fr)	2005-12-22	2006-12-20	Formulations orales contenant de la tigecycline

Publications (1)

Publication Number	Publication Date
NO20082547L true NO20082547L (no)	2008-09-22

Family

ID=37964562

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20082547A NO20082547L (no)	2005-12-22	2008-05-30	Orale formuleringer omfattende tigecycline

Country Status (14)

Country	Link
US (1)	US20080014256A1 (fr)
EP (1)	EP1965770A2 (fr)
KR (1)	KR20080080205A (fr)
CN (1)	CN101340895A (fr)
AU (1)	AU2006331688A1 (fr)
BR (1)	BRPI0620646A2 (fr)
CA (1)	CA2632213A1 (fr)
CR (1)	CR10124A (fr)
EC (1)	ECSP088635A (fr)
GT (1)	GT200800107A (fr)
IL (1)	IL191789A0 (fr)
NO (1)	NO20082547L (fr)
RU (1)	RU2008120672A (fr)
WO (1)	WO2007075794A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101313702B1 (ko)	2005-02-03	2013-10-04	와이어쓰	제피티니브 및/또는 에를로티니브 내성암 치료용 약제학적 조성물
EP1942937A1 (fr)	2005-11-04	2008-07-16	Wyeth	Combinaisons antineoplasiques a base d'inhibiteur de mtop, d'herceptine et/ou de khi-272
US8022216B2 (en)	2007-10-17	2011-09-20	Wyeth Llc	Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
US9107929B2 (en)	2008-05-01	2015-08-18	Ranbaxy Laboratories Limited	Stable parenteral formulations of tigecycline
BRPI0914790A2 (pt)	2008-06-17	2015-10-20	Wyeth Llc	uso de um composto de vinorelbina e um composto de hki-272, composição farmacêutica e produto e kit para o tratamento de neoplasma
US8669273B2 (en)	2008-08-04	2014-03-11	Wyeth Llc	Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine
DK3000467T3 (da)	2009-04-06	2023-03-27	Wyeth Llc	Behandling med neratinib mod brystkræft
CA2780332C (fr) *	2009-11-09	2018-01-30	Wyeth Llc	Spheroides de medicament enrobes et utilisations de ceux-ci pour eliminer ou reduire des affections telles que le vomissement et la diarrhee
KR101799304B1 (ko)	2010-05-12	2017-11-20	렘펙스 파머수티클스 인코퍼레이티드	테트라사이클린 조성물
DK3244878T3 (da) *	2015-01-12	2022-10-17	Enteris Biopharma Inc	Faste orale sammensætningsformer
US20210161918A1 (en) *	2018-01-10	2021-06-03	The University Of North Carolina At Chapel Hill	Tigecycline for topical treatment of root canal space
CN111166729A (zh) *	2020-03-19	2020-05-19	珠海赛隆药业股份有限公司	一种口服的替加环素肠溶微球及其制备方法
CN112577917A (zh) *	2020-12-28	2021-03-30	瀚晖制药有限公司	注射用替加环素中有色杂质的检测方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3026248A (en) *	1959-09-11	1962-03-20	Pfizer & Co C	Thioglycerol and formaldehyde sulfoxylate stabilized tetracycline antibiotics in polyhydric alcohol solvents
US3219529A (en) *	1962-10-04	1965-11-23	American Cyanamid Co	Stable tetracycline solutions
US4837030A (en) *	1987-10-06	1989-06-06	American Cyanamid Company	Novel controlled release formulations of tetracycline compounds
US5281628A (en) *	1991-10-04	1994-01-25	American Cyanamid Company	9-amino-7-(substituted)-6-demethyl-6-deoxytetracyclines
US5494903A (en) *	1991-10-04	1996-02-27	American Cyanamid Company	7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US5167964A (en) *	1992-02-14	1992-12-01	Warner-Lambert Company	Semi-enteric drug delivery systems and methods for preparing same
US5420272A (en) *	1992-08-13	1995-05-30	American Cyanamid Company	7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
US5328902A (en) *	1992-08-13	1994-07-12	American Cyanamid Co.	7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
SG47520A1 (en) *	1992-08-13	1998-04-17	American Cyanamid Co	New method for the production of 9-amino-6-demethyl-6-deoxytetracycline
AU1279095A (en) *	1994-02-17	1995-09-04	Pfizer Inc.	9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics
US5567693A (en) *	1994-12-13	1996-10-22	American Cyanamid Company	Method for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth
US6063775A (en) *	1997-04-29	2000-05-16	Berman; Charles L.	Retardation of metalloproteinase incidental to HIV and/or AIDS
US5908838A (en) *	1998-02-19	1999-06-01	Medics Pharmaceutical Corporation	Method for the treatment of acne
US6015803A (en) *	1998-05-04	2000-01-18	Wirostko; Emil	Antibiotic treatment of age-related macular degeneration
US6015804A (en) *	1998-09-11	2000-01-18	The Research Foundation Of State University Of New York	Method of using tetracycline compounds to enhance interleukin-10 production
US5998390A (en) *	1998-09-28	1999-12-07	The Research Foundation Of State University Of New York	Combination of bisphosphonate and tetracycline
US6506740B1 (en) *	1998-11-18	2003-01-14	Robert A. Ashley	4-dedimethylaminotetracycline derivatives
US20040131628A1 (en) *	2000-03-08	2004-07-08	Bratzler Robert L.	Nucleic acids for the treatment of disorders associated with microorganisms
MXPA02009482A (es) *	2000-03-31	2004-05-14	Tufts College	Compuestos tetraciclinas sustituidos con grupos 7- y 9- carbamato, urea, tiourea, tiocarbamato y heteroaril-amino.
CN1450989A (zh) *	2000-07-07	2003-10-22	塔夫茨大学信托人	7－取代的四环素化合物
EA013908B1 (ru) *	2000-07-07	2010-08-30	Трастис Оф Тафтс Коллидж	Замещенные соединения миноциклина (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния млекопитающего
WO2002072532A1 (fr) *	2001-03-13	2002-09-19	Paratek Pharmaceuticals, Inc.	Composes de tetracycline substitues en position 7,9
JP2004530661A (ja) *	2001-03-14	2004-10-07	パラテックファーマシューティカルズインコーポレイテッド	抗真菌剤としての置換テトラサイクリン化合物
EP2329826A1 (fr) *	2001-07-13	2011-06-08	Paratek Pharmaceuticals, Inc.	Tetracyclines pour le traitement de la sclérose en plaques
EP2311799A1 (fr) *	2002-01-08	2011-04-20	Paratek Pharmaceuticals, Inc.	Composés de tétracycline 4-dedimethylamino
US6958161B2 (en) *	2002-04-12	2005-10-25	F H Faulding & Co Limited	Modified release coated drug preparation
CA2492273C (fr) *	2002-07-12	2013-02-05	Paratek Pharmaceuticals, Inc.	Composes de tetracycline substituee en 3, 10, et 12a
WO2004017925A2 (fr) *	2002-08-23	2004-03-04	Genome Therapeutics Corporation	Methodes et reactifs de prevention des bacteriemies
US20040106590A1 (en) *	2002-08-29	2004-06-03	Barry Eisenstein	Methods and reagents for treating infections of clostridium difficile and diseases associated therewith
US20050148553A1 (en) *	2003-09-05	2005-07-07	Testa Raymond T.	Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis
GB2414668B (en) *	2004-06-03	2009-07-29	Dexcel Ltd	Tetracycline modified release delivery system

2006
- 2006-12-20 WO PCT/US2006/048621 patent/WO2007075794A2/fr not_active Ceased
- 2006-12-20 CN CNA2006800482101A patent/CN101340895A/zh active Pending
- 2006-12-20 AU AU2006331688A patent/AU2006331688A1/en not_active Abandoned
- 2006-12-20 KR KR1020087017661A patent/KR20080080205A/ko not_active Withdrawn
- 2006-12-20 RU RU2008120672/15A patent/RU2008120672A/ru not_active Application Discontinuation
- 2006-12-20 CA CA002632213A patent/CA2632213A1/fr not_active Abandoned
- 2006-12-20 EP EP06847833A patent/EP1965770A2/fr not_active Withdrawn
- 2006-12-20 BR BRPI0620646-8A patent/BRPI0620646A2/pt not_active Application Discontinuation
- 2006-12-21 US US11/642,509 patent/US20080014256A1/en not_active Abandoned
2008
- 2008-05-28 IL IL191789A patent/IL191789A0/en unknown
- 2008-05-30 NO NO20082547A patent/NO20082547L/no unknown
- 2008-06-17 GT GT200800107A patent/GT200800107A/es unknown
- 2008-06-27 CR CR10124A patent/CR10124A/es not_active Application Discontinuation
- 2008-07-18 EC EC2008008635A patent/ECSP088635A/es unknown

Also Published As

Publication number	Publication date
US20080014256A1 (en)	2008-01-17
CR10124A (es)	2008-09-23
EP1965770A2 (fr)	2008-09-10
ECSP088635A (es)	2008-08-29
KR20080080205A (ko)	2008-09-02
CA2632213A1 (fr)	2007-07-05
WO2007075794A2 (fr)	2007-07-05
AU2006331688A1 (en)	2007-07-05
IL191789A0 (en)	2008-12-29
CN101340895A (zh)	2009-01-07
WO2007075794A3 (fr)	2007-08-16
RU2008120672A (ru)	2010-01-27
GT200800107A (es)	2008-11-19
BRPI0620646A2 (pt)	2011-11-22

Publication	Publication Date	Title
NO20082547L (no)	2008-09-22	Orale formuleringer omfattende tigecycline
DK4072332T3 (da)	2025-01-20	Fugtige, orale sammensætninger
NO20092611L (no)	2009-09-11	Krystallinsk faststoff Rasagilin base
NO20052306D0 (no)	2005-05-11	Dispergerbare farmasoytiske blandinger.
DK3984528T3 (da)	2023-07-31	Farmaceutiske sammensætninger, som omfatter nilotinib
WO2007027527A3 (fr)	2007-05-24	Composes d'isoindole-imide et compositions renfermant ceux-ci et procedes d'utilisation de ceux-ci
EA200802008A1 (ru)	2009-04-28	Фармацевтические композиции
DK3219705T3 (da)	2020-04-14	Farmaceutiske sammensætninger af den amorfe form af n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinolin-3-carboxamid
NO20042807L (no)	2004-07-02	Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser
LTC1608344I2 (lt)	2019-03-12	Per burną vartojamos kladribino kompozicijos
CY1113594T1 (el)	2016-06-22	Φουμαρικο αλας της (αλφα s, βητα r)-6-βρωμο-αλφα-[2-(διμεθυλαμινο)αιθυλ]-2-μεθοξυ-αλφα-1-ναφθαλινυλ-βητα-φαινυλ-3-κινολινοαιθανολης
NO20054329D0 (no)	2005-09-20	Adamantanderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som innbefatter slike
ECSP22040921A (es)	2022-06-30	Composición farmacéutica que comprende selexipag
NO20063393L (no)	2006-07-21	Farmasoytiske preparater
EA200600590A1 (ru)	2006-08-25	Фармацевтические композиции модафинила с модифицированным высвобождением
ATE552832T1 (de)	2012-04-15	Antidepressivum-propharmaka
CL2008000949A1 (es)	2008-10-03	Compuestos derivados de 2,3-benzodiazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos psicoticos.
EA200601596A1 (ru)	2007-04-27	Улучшенный состав 6-меркаптопурина
BRPI0417205A (pt)	2007-02-06	composições farmacêuticas
BRPI0411820B8 (pt)	2021-05-25	composição farmacêutica para administração parenteral, e seus usos
DK1879581T3 (da)	2008-12-15	4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater som lægemidler til behandling af infertilitet
TR200903548A1 (tr)	2010-11-22	Oral yolla dağılan emoksipin bileşimleri
TW200724145A (en)	2007-07-01	Substituted acrylamide derivatives and pharmaceutical compositions thereof
BRPI0820659A2 (pt)	2019-09-24	composto, prodroga de composto, composição farmacêutica e formulação oral e uso de composto.
CR20220174A (es)	2022-05-27	Composición farmacéutica que comprende selexipag